1
|
Keppler D: The roles of MRP2, MRP3,
OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab
Dispos. 42:561–565. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Memon N, Weinberger BI, Hegyi T and
Aleksunes LM: Inherited disorders of bilirubin clearance. Pediatr
Res. 79:378–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Radlovic N: Hereditary
hyperbilirubinemias. Srp Arh Celok Lek. 142:257–260. 2014.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Sticova E, Elleder M, Hulkova H, Luksan O,
Sauer M, Wunschova-Moudra I, Novotny J and Jirsa M: Dubin-Johnson
syndrome coinciding with colon cancer and atherosclerosis. World J
Gastroenterol. 19:946–950. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Uchiumi T, Tanamachi H, Kuchiwaki K,
Kajita M, Matsumoto S, Yagi M, Kanki T and Kang D: Mutation and
functional analysis of ABCC2/multidrug resistance protein 2 in a
Japanese patient with Dubin-Johnson syndrome. Hepatol Res.
43:569–575. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Li P, Wang Y, Zhang J, Geng M and Li Z:
Dubin-Johnson syndrome with multiple liver cavernous hemangiomas:
Report of a familial case. Int J Clin Exp Pathol. 6:2636–2639.
2013.PubMed/NCBI
|
7
|
Chen ZS and Tiwari AK: Multidrug
resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic
diseases. FEBS J. 278:3226–3245. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Sticova E and Jirsa M: New insights in
bilirubin metabolism and their clinical implications. World J
Gastroenterol. 19:6398–6407. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Xiang R, Fan LL, Huang H, Cao BB, Li XP,
Peng DQ and Xia K: A novel mutation of GATA4 (K319E) is responsible
for familial atrial septal defect and pulmonary valve stenosis.
Gene. 534:320–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sunyaev S, Ramensky V and Bork P: Towards
a structural basis of human non-synonymous single nucleotide
polymorphisms. Trends Genet. 16:198–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ng PC and Henikoff S: SIFT: Predicting
amino acid changes that affect protein function. Nucleic Acids Res.
31:3812–3814. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Schwarz JM, Rödelsperger C, Schuelke M and
Seelow D: MutationTaster evaluates disease-causing potential of
sequence alterations. Nat Methods. 7:575–576. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Fujiwara R, Maruo Y, Chen S and Tukey RH:
Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in
understanding breast milk-induced neonatal hyperbilirubinemia.
Toxicol Appl Pharmacol. 289:124–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Christensen RD and Yaish HM: Hemolytic
disorders causing severe neonatal hyperbilirubinemia. Clin
Perinatol. 42:515–527. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Emi Y, Yasuda Y and Sakaguchi M: A
cis-acting five-amino-acid motif controls targeting of ABCC2 to the
apical plasma membrane domain. J Cell Sci. 125:3133–3143. 2012.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Okada H, Kusaka T, Fuke N, Kunikata J,
Kondo S, Iwase T, Nan W, Hirota T, Ieiri I and Itoh S: Neonatal
Dubin-Johnson syndrome: Novel compound heterozygous mutation in the
ABCC2 gene. Pediatr Int. 56:e62–e64. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Devgun MS, El-Nujumi AM, O'Dowd GJ, Barbu
V and Poupon R: Novel mutations in the Dubin-Johnson syndrome gene
ABCC2/MRP2 and associated biochemical changes. Ann Clin Biochem.
49:609–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lee JH, Chen HL, Chen HL, Ni YH, Hsu HY
and Chang MH: Neonatal Dubin-Johnson syndrome: Long-term follow-up
and MRP2 mutations study. Pediatr Res. 59:584–589. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kruer MC, Jepperson T, Dutta S, Steiner
RD, Cottenie E, Sanford L, Merkens M, Russman BS, Blasco PA, Fan G,
et al: Mutations in gamma adducin are associated with inherited
cerebral palsy. Ann Neurol. 74:805–814. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kaufmann KB, Büning H, Galy A, Schambach A
and Grez M: Gene therapy on the move. EMBO Mol Med. 5:1642–1661.
2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
van Dijk R, Beuers U and Bosma PJ: Gene
replacement therapy for genetic hepatocellular jaundice. Clin Rev
Allergy Immunol. 48:243–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Stapelbroek JM, van Erpecum KJ, Klomp LW
and Houwen RH: Liver disease associated with canalicular transport
defects: Current and future therapies. J Hepatol. 52:258–271. 2010.
View Article : Google Scholar : PubMed/NCBI
|